With the aim of ensuring local cancer control and minimising disease recurrence, the interventional science theme will deliver improvements in early detection and diagnosis, surgery, radiotherapy, novel localised therapies and innovations to monitor therapeutic efficacy.

 

To drive uptake and adoption of innovations within the NHS, our Centre, including with national collaborators, will address the regulatory challenges associated with novel interventions. Early detection efforts will focus on bringing interventional trials (e.g. targeted screening) to risk-stratified populations. Technological innovation will focus on the continued development of ultrasensitive low-cost devices to detect specific early disease signals, supported by clinical positioning and adoption strategies. Surgery remains the most important curative option for most solid malignancies. We will continue to develop techniques and technologies to improve surgical precision and strategies for local control of advanced-stage cancers.

 

 


     

     

     

    If you have any questions relating to the Interventional Science theme please contact Chloe Stockford (chloe.stockford@imperial.ac.uk)